HomeMarketsSharesRaffles Medical

Trade Raffles Medical - BSLsg CFD

Market is not available at the momentMarket information is presented
as of 2026-10-15T08:46:35+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.0068
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
SGD 1,000.00
Overnight funding adjustment
Charges from full value of position
-0.01393 %
(-SGD 2.79)

Trade size with leverage ~ SGD 20,000.00

Money from leverage ~ $SGD 19,000.00


-0.01393%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
SGD 1,000.00
Overnight funding adjustment
Charges from full value of position
-0.00799 %
(-SGD 1.60)

Trade size with leverage ~ SGD 20,000.00

Money from leverage ~ $SGD 19,000.00


-0.00799%
Overnight funding adjustment time21:00 (UTC)
CurrencySGD
Min traded quantity10
Margin5.00%
Stock exchangeSingapore
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close0.8241
Open0.8241
1-Year Change-18.32%
Day's Range0.8141 - 0.8241

Trade Raffles Medical - BSLsg

Track the Raffles Medical share price today and spot the best levels for profitable CFD trades

Raffles Medical Group Ltd is a full spectrum health services company founded in Singapore in 1976. The company served over 2 million clients in 2020 with operations in 14 cities across five countries. As with many other companies, Raffles Medical initially suffered greatly from closures enacted due to the coronavirus pandemic. The company was unable to offer any non-essential health services which form a large part of its revenue.

After an initial period of closures the company was able to devise new income streams through providing Covid testing to migrant workers and other travellers entering the Southeast Asian countries where they have operations. The company is currently the largest private health care services provider in Singapore.

Raffles Medical stock price was listed on the Singapore Stock Exchange mainboard on April 11, 1997 and trades under the ticker symbol BSL. Raffles Medical operates three primary business lines. The first is healthcare, which offers insurance services, pharmaceutical products and services as well as aftercare coverage for patients. The hospital division offers emergency and surgery services as well as medical devices for patient use. Finally the company has an active investment division, primarily dealing with the real estate holdings of the group.

The Raffles Medical (BSL) stock has traded within the 52-week range of S$0.75 - S$1.14 at an average volume of close to 53 million shares per day. The stock began 2021 at S$0.995 before dipping to a low of S$0.925 near the end of January and then rising steadily to S$1.09 by late March.

BSL has a market capitalisation of just over $2 billion Singapore dollars and posted a net income of S$65 million in 2020. Revenues increased to S$568 million in 2020, up 8.8 per cent from the previous year.

The latest BSL stock chart is updated on the SGX as well as on Capital.com. By accessing the live price chart on Capital.com you can view the Raffles Medical Group share price in real time.

You can trade BSL now with CFDs and open a long or short position, depending on whether you feel the price will rise or fall. CFDs allow you to profit from upward or downward fluctuations in the Raffles Medical (SGX) stock price at Capital.com. Track the BSL stock price and include this Singapore-founded multinational medical services company in your investment portfolio.

Latest shares articles

TAURON stock forecast
TAURON stock forecast: H1 earnings
TAURON is a Polish energy group. In the first half of 2026, revenue was broadly flat, while EBITDA and net profit fell amid higher CO2 allowance costs and coal consumption. Explore third-party analyst targets and technicals. Past performance is not a reliable indicator of future results.
12:04, 12 October 2026
Puma stock forecast
Puma stock forecast: Anta stake deal cleared
Puma is a German sportswear company. Chinese regulators have cleared Anta Sports’ proposed acquisition of an approximately 29% stake, with completion expected before the end of 2026. Explore third-party PUM price targets. Past performance is not a reliable indicator of future results.
10:19, 12 October 2026
Dino Polska stock forecast
Dino Polska stock forecast: H1 sales growth slows
Dino Polska is a Polish grocery retailer. In H1 2026, revenue rose 12.5% year on year to 18.0bn PLN, while like-for-like sales growth slowed to 2.2%. Explore third-party DNP price targets and technical analysis. Past performance is not a reliable indicator of future results.
08:27, 12 October 2026
A GameStop store in Portland, Oregon
GameStop stock forecast: debt exchange, Q2 profit
GameStop is a US video-game retailer. In Q2 fiscal 2026, net sales fell to $790.2m, while operating income rose to $160.2m. Explore third-party GME price targets and technical analysis. Past performance is not a reliable indicator of future results.
14:06, 7 October 2026

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready